Orbita Acquires Wellbe Assets

AVIA Adds Three Leading Academic and Community Health Systems to National Network

AVIA’s digital transformation network maintains 100% member retention for first half of 2023, demonstrating the importance of digital

ZeOmega Integrates Social Determinants of Health (SDOH) Solution with Microsoft Cloud for Healthcare

The new SDOH add-in to Microsoft Cloud for Healthcare broadens healthcare organizations’ understanding of the needs of populations and individuals, automates workflow actions, and improves health outcomes

Amerigo Scientific Introduces Water Purification Systems for Life Science Research

Evoke launches audience intelligence offering to unlock the full commercial potential of life sciences brands

Leading global health and life science brand Evoke has launched a major new audience intelligence service offering to benefit their roster of international pharma and life science clients

CD Computabio Unleashes the Power of Computational Biology with Innovative Virtual Screening Service

Bios Health Group Enters the Market to Offer Investment-Driven and Clinical Development Optimization Strategies for Biotech and Life Science Companies

Bios Health Group Enters the Market to Offer Investment-Driven and Clinical Development Optimization Strategies for Biotech and Life Science Companies Accelerating Biotech Success

Health Plan Alliance Selects 1upHealth as Preferred Health Data Interoperability Partner

NIH and Exothera collaborate to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US

Exothera S.A. has announced that the National Institutes of Health, the US’s medical research agency, has selected them to develop the manufacturing process for NIH’s intranasal vaccine against SARS-CoV-2.

SSI Strategy and NDA Group Combine to Form Best-in-Class Global Life Sciences Consultancy

SSI Strategy has announced that it has entered into a definitive agreement to acquire NDA Group AB. This strategic combination will create a premier consultancy, specializing in guiding drug development companies from concept to commercialization.

ICS/ICB leaders Penny Dash and Paul Miller announced as speakers for the NHS Transformation Symposium

Mtech Access has announced that its annual NHS Transformation Symposium, this September, will feature guest speakers Penny Dash and Paul Miller, who hold strategic leadership roles in an Integrated Care Systemand Board, respectively.

RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award

RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award Two-day educational conference tops the experiential/event marketing category at the Sales and Marketing Technology Awards 2023

Form Bio Announces First Half 2023 Achievements

Key Partnerships, Breakthrough Technology Advancement, Key Leadership Hires, and Industry Recognition Demonstrate Strong Success

Phastar Appoints Graham Clark as New Chief Executive Officer

Phastar Appoints Graham Clark as New Chief Executive Officer Phastar Sets Course for Further Growth with New CEO Appointment

AI-Powered Healthcare: How Chatbots Are Transforming Healthcare

Healthcare chatbots are set to change how we look after our health. In the future, these digital helpers will talk more like humans, making it feel like chatting with a friend. They'll learn from each conversation, offering better advice over time. These chatbots will work alongside doctors, helping screen and understand patients' problems. They'll speak many languages, team up with gadgets like smartwatches to monitor our health, and be available 24/7. Plus, they'll remind us about medicines and appointments, keep our health data safe, and even help with emotional well-being. In short, they'll make healthcare more personal, easy, and accessible for everyone.

Click Therapeutics Launches Additional Randomized Clinical Study in Migraine, Conducted in Partnership with Syneos Health

Recent Cash Injection Boosts VectorBuilder to Unicorn Status

VectorBuilder's latest cash injection drives them towards a CDMO facility for the manufacturing of plasmids, mRNA, AAV, lentivirus, cell lines, and a variety of viral and non-viral vectors

ArisGlobal to Relocate Global Headquarters to Boston Area

ArisGlobal's move to the Greater Boston area reflects growth needs and geographically positions the life sciences SaaS provider among leading biopharmaceutical organizations.

Huateng Pharma Develops CAS NO.156-83-2 (Minoxidil Intermediate) Against Hair Loss

About Huateng Pharma Huateng Pharma is a global provider in contract development and manufacturing for intermediates. With our focus on operational excellence, and the integration of manufacturing operations with EHS, quality assurance, quality control, regulatory, supply chain management and project management, we can manufacture, scale-up and supply high-quality intermediates and APIs from our China facility. Contact us Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818

Genedata Selector 9.0 Automates Critical Quality Attribute Assessment of Cell and Gene Therapy Products